Requena, G. ., Czira, A. ., Banks, V. ., Wood, R. ., Tritton, T. ., Castillo, C. ., … Ismaila, A. S. (2023). Comparative Effectiveness of Umeclidinium/Vilanterol versus Indacaterol/Glycopyrronium on Moderate-to-Severe Exacerbations in Patients with Chronic Obstructive Pulmonary Disease in Clinical Practice in England. Int J Chron Obstruct Pulmon Dis, 18, 2039–2054. http://doi.org/10.2147/copd.s408688
exacerbations
Chen, S. ., Miravitlles, M. ., Rhee, C. K., Pavord, I. D., Jones, R. ., Carter, V. ., … Price, D. B. (2022). Patients with Chronic Obstructive Pulmonary Disease and Evidence of Eosinophilic Inflammation Experience Exacerbations Despite Receiving Maximal Inhaled Maintenance Therapy. Int J Chron Obstruct Pulmon Dis, 17, 2187–2200. http://doi.org/10.2147/copd.s378649
Sansbury, L. B., Lipson, D. A., Bains, C. ., Anley, G. A., Rothnie, K. J., & Ismaila, A. S. (2022). Disease Burden and Healthcare Utilization Among Patients with Chronic Obstructive Pulmonary Disease (COPD) in England. Int J Chron Obstruct Pulmon Dis, 17, 415–426. http://doi.org/10.2147/copd.s336158
Sansbury, L. B., Rothnie, K. J., Bains, C. ., Compton, C. ., Anley, G. ., & Ismaila, A. S. (2021). Healthcare, Medication Utilization and Outcomes of Patients with COPD by GOLD Classification in England. Int J Chron Obstruct Pulmon Dis, 16, 2591–2604. http://doi.org/10.2147/copd.s318969